Wikipedia:Articles for deletion/Tan Yinglan (2nd nomination)
:The following discussion is an archived debate of the proposed deletion of the article below. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review). No further edits should be made to this page.
The result was no consensus__EXPECTED_UNCONNECTED_PAGE__. Doczilla Ohhhhhh, no! 03:08, 22 June 2024 (UTC)
=[[:Tan Yinglan]]=
{{Special:Prefixindex/Wikipedia:Articles for deletion/Tan Yinglan}}
:{{la|1=Tan Yinglan}} – (
:({{Find sources AFD|title=Tan Yinglan}})
Factors do not appear to have meaningfully changed since the prior discussion. He's an active businessperson, and Insignia Ventures Partners may be notable but he does not appear so as an author. Star Mississippi 01:38, 1 June 2024 (UTC)
- Note: This discussion has been included in the deletion sorting lists for the following topics: People, Authors, Businesspeople, and Singapore. Star Mississippi 01:38, 1 June 2024 (UTC)
- Keep per https://www.bloomberg.com/news/articles/2021-11-19/singapore-s-insignia-ventures-intensifies-push-into-healthtech, https://www.ft.com/content/8c484648-f4b7-11e9-a79c-bc9acae3b654, https://www.reuters.com/technology/insignia-ventures-raises-516-mln-bets-southeast-asian-tech-firms-2022-08-01/, https://techcrunch.com/2017/09/13/insignia-venture-partners-fund-25-million-yinglan-tan/. There is also coverage in New Straits Times [https://www.proquest.com/docview/916085799/fulltext/632AA6706D214635PQ/1?accountid=196403][https://www.proquest.com/docview/2333286069/fulltext/632AA6706D214635PQ/2?accountid=196403]. 182.190.216.63 (talk) 14:00, 7 June 2024 (UTC)
:
{{resize|91%|Relisted to generate a more thorough discussion and clearer consensus.}}
Please add new comments below this notice. Thanks, ✗plicit 02:44, 8 June 2024 (UTC)
:
{{resize|91%|Relisted to generate a more thorough discussion and clearer consensus.}}
Relisting comment: Anyone want to assess the sources offered by the IP editor?
Please add new comments below this notice. Thanks, Liz Read! Talk! 02:19, 15 June 2024 (UTC)
:Comment here's a start on assessing the newly identified sources:
:* https://www.bloomberg.com/news/articles/2021-11-19/singapore-s-insignia-ventures-intensifies-push-into-healthtech – free version here[https://finance.yahoo.com/news/singapore-insignia-ventures-intensifies-push-091414337.html] just regurgitating information from the company
:* https://www.ft.com/content/8c484648-f4b7-11e9-a79c-bc9acae3b654 - paywalled, can’t access
:* https://www.reuters.com/technology/insignia-ventures-raises-516-mln-bets-southeast-asian-tech-firms-2022-08-01/ this is regurgitating information from the company with a tiny bit of commentary on the market as a while; no bio on Tan
:* https://techcrunch.com/2017/09/13/insignia-venture-partners-fund-25-million-yinglan-tan/ - could be significant coverage with some biographical details; even though this is a capital-raise article it seems to be drawing on other editorial resources for the info on Tan
:* New Straits Times - paywalled, can’t access
: Oblivy (talk) 02:53, 15 June 2024 (UTC)
{{clear}}
:The above discussion is preserved as an archive of the debate. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review). No further edits should be made to this page.